Investigators surveyed 16 private payers to learn their views on coverage for confirmatory diagnostics after a positive, noncovered MCED test.
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced that the Centers for Medicare & Medicaid Services’ (CMS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results